These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2996146)

  • 1. Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist.
    Wieloch T
    Science; 1985 Nov; 230(4726):681-3. PubMed ID: 2996146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in excitatory amino acid receptor binding in the intact and decorticated rat neostriatum following insulin-induced hypoglycemia.
    Westerberg E; Wieloch TW
    J Neurochem; 1989 May; 52(5):1340-7. PubMed ID: 2565371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The specific NMDA receptor antagonist AP-7 attenuates focal ischemic brain injury.
    Roman R; Bartkowski H; Simon R
    Neurosci Lett; 1989 Sep; 104(1-2):19-24. PubMed ID: 2554220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
    Foster AC; Wong EH
    Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term development of selective neuronal loss and the mechanism of protection by 2-amino-7-phosphonoheptanoate in a rat model of incomplete forebrain ischaemia.
    Swan JH; Evans MC; Meldrum BS
    J Cereb Blood Flow Metab; 1988 Feb; 8(1):64-78. PubMed ID: 2828386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen.
    Clow DW; Jhamandas K
    J Pharmacol Exp Ther; 1989 Feb; 248(2):722-8. PubMed ID: 2563769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isomers of 2-amino-7-phosphonoheptanoic acid as antagonists of neuronal excitants.
    Perkins MN; Collins JF; Stone TW
    Neurosci Lett; 1982 Sep; 32(1):65-8. PubMed ID: 6755315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
    Marrannes R; Willems R; De Prins E; Wauquier A
    Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Methyl-D-aspartate and L-aspartate activate distinct receptors in piriform cortex.
    ffrench-Mullen JM; Hori N; Carpenter DO
    Cell Mol Neurobiol; 1984 Jun; 4(2):185-90. PubMed ID: 6091885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NMDA receptor: central role in pain inhibition in rat periaqueductal gray.
    Jacquet YF
    Eur J Pharmacol; 1988 Sep; 154(3):271-6. PubMed ID: 2853058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-methyl-D-aspartate antagonist, 2-amino-7-phosphonoheptanoate, produces phencyclidine-like behavioral effects in rats.
    Compton RP; Contreras PC; O'Donohue TL; Monahan JB
    Eur J Pharmacol; 1987 Apr; 136(1):133-4. PubMed ID: 3297738
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection by NMDA antagonists against selective cell loss following transient ischaemia.
    Swan JH; Meldrum BS
    J Cereb Blood Flow Metab; 1990 May; 10(3):343-51. PubMed ID: 2158499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of NMDA receptors in non-convulsive epilepsy in WAG/Rij rats.
    Peeters BW; van Rijn CM; Vossen JM; Coenen AM
    Life Sci; 1990; 47(6):523-9. PubMed ID: 2169562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Amino-7-phosphonoheptanoic acid, a selective antagonist of N-methyl-D-aspartate, prevents barbital withdrawal-induced convulsions and the elevation of cerebellar cyclic GMP in dependent rats.
    McCaslin PP; Morgan WW
    Neuropharmacology; 1987 Jul; 26(7A):731-5. PubMed ID: 2819762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L-cysteine-sulphinate and L-aspartate, mixed excitatory amino acid agonists, on the membrane potential of cat caudate neurons.
    Turski WA; Herrling PL; Do KQ
    Brain Res; 1987 Jun; 414(2):330-8. PubMed ID: 3304528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of NMDA and 2-amino-7-phosphonoheptanoate focal injection into the ventrolateral thalamic nucleus on the high pressure neurological syndrome in the rat.
    Millan MH; Wardley-Smith B; Halsey MJ; Meldrum BS
    Brain Res; 1990 Jan; 507(2):354-6. PubMed ID: 2159822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of neuronal activity of locus coeruleus in rats induced by excitatory amino acids.
    Ping HX; Wu HQ; Liu GQ
    Zhongguo Yao Li Xue Bao; 1990 May; 11(3):193-5. PubMed ID: 2087991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA receptor blockade inhibits glutamate-induced kindling of the rat amygdala.
    Croucher MJ; Bradford HF
    Brain Res; 1990 Jan; 506(2):349-52. PubMed ID: 1967970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the interaction of 2-amino-7-phosphono-heptanoic acid and quinolinic acid in mice.
    Perkins MN; Stone TW
    Eur J Pharmacol; 1983 May; 89(3-4):297-300. PubMed ID: 6347698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unified approach to systematic isosteric substitution for acidic groups and application to NMDA antagonists related to 2-amino-7-phosphonoheptanoate.
    Chenard BL; Lipinski CA; Dominy BW; Mena EE; Ronau RT; Butterfield GC; Marinovic LC; Pagnozzi M; Butler TW; Tsang T
    J Med Chem; 1990 Mar; 33(3):1077-83. PubMed ID: 2155321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.